Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 35.71% vs 18.87% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is 500.00% vs -140.00% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 420.00% vs 58.33% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Biofrontera, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 144.29% vs -22.22% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 35.71% vs 18.87% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 184.85% vs -24.53% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 500.00% vs -140.00% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 178.69% vs -24.49% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 420.00% vs 58.33% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






